Results 21 - 30 of 58 : Previous 1 2 3 4 5 6 Next
5 Health Care Companies Flying Below the Radar
They've all got a potentially winning story.
It picks up an asset that's more than half its size.
Maybe what glitters really is gold.
The drugmaker marks its first quarter under new management.
The pharmaceutical's latest results show continuing improvement.
Alpharma lowers its financial guidance for 2008.
These companies are buying back their shares. Should you buy their shares, too?
Endo sues to protect a lead drug from generic competition.
The pharmaceutical starts another study for its proposed pain drug.
Activist Investor Attack at Endo
An Endo shareholder releases an open letter in an SEC filing.